(800)525-7111 Free Consultation

Zantac Breast Cancer Risk

Riddle Brantley LLP   |  April 22, 2020   |  

Since an independent lab discovered NDMA contamination in ranitidine in late 2019, many have wondered about potential Zantac breast cancer risk.

Here’s what you need to know about the potential link between Zantac and breast cancer:

Zantac Cancer Risk

Zantac Breast Cancer Risk - Riddle & BrantleyIn early 2020, the FDA warned that Zantac is contaminated with “elevated” levels of potentially cancer-causing NDMA. In its order, the FDA requested that all Zantac and generic ranitidine manufacturers immediately stop selling the common heartburn medication.

NDMA is a known “probably human carcinogen,” meaning that it may cause cancer, potentially including breast cancer.

Research is ongoing, but it is believed that NDMA in Zantac may cause the following types of cancer, including breast cancer:

“Does Zantac cause breast cancer?”

Zantac Cancer Risks - Riddle & BrantleyThere is significant Zantac breast cancer risk. While the FDA has not warned of specific cancers potentially being associated with Zantac use, it has cautioned that Zantac is contaminated with NDMA, which may cause many types of cancer, including breast cancer.

In 2008, a peer-reviewed study was published that examined the relationship between H2 antihistamine-blockers like Zantac and breast cancer. The results of that study did not establish a causal link between ranitidine and breast cancer, but did suggest that those who regularly took these medications were at increased risk of ductal carcinoma — a type of breast cancer.

Currently, more research is underway at the Sloane Memorial Cancer Center to determine which specific cancers may be caused by NDMA-contaminated Zantac.

Zantac Breast Cancer Lawsuits

Thousands of Zantac cancer lawsuits are expected to be filed in the months and years ahead as manufacturers defend themselves against claims that Zantac and ranitidine are contaminated with dangerous, cancer-causing NDMA.

In late 2019, a Florida woman filed a Zantac breast cancer lawsuit against four manufacturers, alleging that ranitidine-containing Zantac caused her breast cancer.

In a statement, the Florida woman’s attorney said that “If only the makers of Zantac had put aside their greed and heeded the 2008 peer-reviewed study … Jill Goldstein would not be going through the hell that she is subjected to now.”

Have you been diagnosed with breast cancer after taking Zantac?

If you’ve suffered from breast cancer (or another type of cancer listed above) after taking Zantac or generic ranitidine, you may have a claim for compensation.

You may qualify for a Zantac breast cancer lawsuit, and our experienced Zantac cancer lawyers can help.

For a FREE consultation with an experienced dangerous drugs attorney handling Zantac breast cancer claims, please call 1-800-525-7111.

There are no upfront costs and you won’t pay any attorney fees unless we win your case and you receive financial compensation.

You may also qualify for a Zantac lawsuit if you’ve been diagnosed with any of the cancers listed above after taking Zantac or ranitidine for an extended period of time.

Call 1-800-525-7111 today for a FREE, no-obligation consultation with a Zantac cancer lawyer about your claim related to breast cancer or other type of cancer.

“If NDMA-contaminated Zantac or ranitidine caused your cancer, that’s wrong and you deserve justice.”

-Gene Riddle, managing partner and attorney, Riddle & Brantley

There is significant risk of Zantac-related breast cancer for those who have taken potentially NDMA-contaminated Zantac or ranitidine. Many other cancers may have been caused by Zantac, as well.

If you believe you have a Zantac cancer claim, please call 1-800-525-7111 today to speak with an experienced Zantac lawsuit lawyer at Riddle & Brantley.

We will evaluate your claim and help you determine your best legal options.

The consultation is free and there are no upfront costs or attorney fees unless we win your case and you receive financial compensation.

Justice Counts.